Fujifilm Toyama Chemical Licenses Cancer “Theragnostic” Agent to Novartis Subsidiary

December 4, 2018
Fujifilm Toyama Chemical said on December 3 that it has signed a licensing agreement with Advanced Accelerator Applications (AAA), a subsidiary of Novartis, for the development and commercialization of a novel small molecule compound for the diagnosis and treatment of...read more